CT imaging reveals that COVID-19 vaccination may protect against severe lung pathology MDPIOpenAccess vaccination vaccine COVID19 coronavirus covid lung pathology infection disease
By Dr. Priyom Bose, Ph.D.Aug 9 2023Reviewed by Benedette Cuffari, M.Sc. The rapid worldwide transmission of the severe acute respiratory syndrome coronavirus 2 led to the coronavirus disease 2019 pandemic. Since the start of the pandemic, scientists worked at an unprecedented pace to develop effective vaccines to protect individuals from contracting this infection.
Currently, the increased prevalence of re-infection can be attributed to the high rate of SARS-CoV-2 genomic mutations. Previous studies on lung sequelae of COVID-19 revealed that most recovered patients exhibit thorax computed tomography abnormalities several months after infection. In particular, ground glass opacities , reticulation, and parenchymal bands/fibrous stripes have been commonly observed.
Related StoriesA total of 100 patients were ultimately included in the study, each of whom had follow-up CT scans at one, three, and six months. The selected participants were vaccinated with at least one dose of a COVID-19 vaccine, whereas the control group included unvaccinated individuals. Twenty-three patients with severe COVID-19 were unvaccinated and ultimately discharged from hospital after treatment. The remaining seventy-seven patients exhibited mild to moderate COVID-19 pneumonia.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Exploring the safety of COVID-19 mRNA vaccines in the elderlyExploring the safety of COVID-19 mRNA vaccines in the elderly JAMANetworkOpen COVID19 covid SARSCoV2 mRNA elderly olderpersons research
Lire la suite »
Is COVID-19 vaccination linked to psoriasis emergence or flare-ups?Is COVID-19 vaccination linked to psoriasis emergence or flare-ups? Biomed_MDPI COVID19 SARSCoV2 psoriasis vaccination vaccines
Lire la suite »
People living with HIV respond well to COVID-19 infection and vaccinationPeople living with HIV respond well to COVID-19 infection and vaccination FrontImmunol HIV COVID19 covid SARSCoV2 vaccination infection
Lire la suite »
Joint COVID and flu autumn booster vaccination programme pushed backNHS England is set to push back the joint COVID-19 and flu autumn booster vaccination programme in a move criticised by clinically vulnerable patients and leading pharmacists
Lire la suite »
Outcome markers in COPD patients with COVID-19Outcome markers in COPD patients with COVID-19 MDPIOpenAccess COPD COVID19 SARSCoV2 outcome markers
Lire la suite »
Role of M2 macrophage-derived exosomes in controlling neutrophil-mediated tissue injury in sepsisRole of M2 macrophage-derived exosomes in controlling neutrophil-mediated tissue injury in sepsis BMC_series macrophage exosomes tissueinjury sepsis M2macrophage neutrophil
Lire la suite »